Tennessee SB2586 regulates stem cell therapies, requiring compliance with FDA standards and physician consent.
Tennessee SB2586 amends state law to regulate stem cell therapies, ensuring they meet FDA standards and requiring physicians to obtain patient consent. The bill mandates that stem cells used in therapies must be retrieved, manufactured, and stored in FDA-registered facilities or those accredited by specified organizations. Physicians must also obtain signed consent forms from patients, detailing the nature of the treatment, its unapproved status by the FDA, potential outcomes, and risks.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.